[{"Assets_0_Q1_USD":44355600000.0,"EarningsPerShareBasic_1_Q1_USD":1.16,"EarningsPerShareDiluted_1_Q1_USD":1.16,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":436500000.0,"NetIncomeLoss_1_Q1_USD":1217400000.0,"StockholdersEquity_0_Q1_USD":14527000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":1049800000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":1048000000.0,"Ticker":"LLY","CIK":"59478","name":"LILLY ELI & CO","OfficialName":"Eli Lilly and Company Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"282856619893.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20180427"}]